
MiniMed Group, Inc.
No annual data found.
MiniMed delivered strong Q4 FY2026 results with net sales of $837 million growing 16% as reported, surpassing $3B in annual revenue for the first time, and provided FY2027 organic revenue growth guidance of approximately 10%
“MiniMed delivered a strong finish to our fiscal year, driven by strength in international markets and continued global adoption of the MiniMed 780G system.”
No Form 4 transactions on record.
Informational purposes only, not investment advice.